These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5817509)

  • 1. [Thiazide therapy of hypertension and its effect on hyperuricemia].
    Namba H; Takayama J; Miyazaki H; Tsuboniwa M
    Nihon Rinsho; 1969 May; 27(5):1483-8. PubMed ID: 5817509
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension.
    Ishimitsu T; Numabe A; Masuda T; Akabane T; Okamura A; Minami J; Matsuoka H
    Hypertens Res; 2009 Nov; 32(11):962-8. PubMed ID: 19696778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experience with prolonged treatment of elderly patients with an oral diuretic: trichlormethiazide. Observations on pressure behavior, electrolyte levels and blood urea, uric acid and glucide metabolism].
    Vizioli A; Ceino A
    Minerva Med; 1967 Feb; 58(16):596-605. PubMed ID: 6021627
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparative study of metoprolol and trichlormethiazide in hypertension.
    Stokkeland OM; Sangvik K; Ditlefsen EM
    Curr Ther Res Clin Exp; 1975 Dec; 18(6):755-68. PubMed ID: 2449
    [No Abstract]   [Full Text] [Related]  

  • 5. [Management of hypertension using methyclothiazide pargyline].
    Rojas Duarte M
    Prensa Med Argent; 1968 Sep; 55(31):1515-8. PubMed ID: 5720927
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of dosage and duration of therapy on the rate of response to methyclothiazide in essential hypertension.
    Soghikian K; Bartenbach DE
    South Med J; 1977 Dec; 70(12):1397-404. PubMed ID: 594788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Esmaloride--a new potassium neutral diuretic combination. Clinical pharmacologic properties].
    Pabst J; Leopold G; Ungethüm W; Simane Z; Bühring KU
    Fortschr Med; 1985 Feb; 103(6):125-9. PubMed ID: 3988214
    [No Abstract]   [Full Text] [Related]  

  • 8. Adverse effect profile of trichlormethiazide: a retrospective observational study.
    Takahashi Y; Nishida Y; Nakayama T; Asai S
    Cardiovasc Diabetol; 2011 May; 10():45. PubMed ID: 21605415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of effects of low dose of spironolactone and a thiazide diuretic in patients with hypertension treated with an angiotensin-converting enzyme inhibitor or an angiotensin type 1 receptor blocker.
    Yutaka M; Mifune M; Kubota E; Itoh H; Saito I
    Clin Exp Hypertens; 2009 Nov; 31(8):648-56. PubMed ID: 20001457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of arterial hypertension with a pargyline and methyclothiazide compound].
    Cruz J; Bezas AG; Cruz HM; de Almeida SS
    Rev Bras Med; 1967 May; 24(5):353-8. PubMed ID: 5603878
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic and hypotensive effects of a new rauwolfia-thiazide combination.
    Hutchison JC
    Geriatrics; 1969 Jul; 24(7):68-74. PubMed ID: 5789861
    [No Abstract]   [Full Text] [Related]  

  • 12. Antihypertensive effect of pargyline and methyclothiazide in combination.
    Sutnick AI; Frankl WS; Fewell JW; Esbenshade JH; Bello CT
    Vasc Dis; 1966 Jun; 3(3):145-55. PubMed ID: 5939435
    [No Abstract]   [Full Text] [Related]  

  • 13. Pargyline hydrochloride combined with methyclothiazide in the treatment of essential hypertension.
    Hamm HJ
    Curr Ther Res Clin Exp; 1966 Aug; 8(8):378-83. PubMed ID: 4958153
    [No Abstract]   [Full Text] [Related]  

  • 14. Parglyline hydrochloride and methyclothiazide combined in the treatment of hypertension in diabetic patients.
    Pickering BI
    Ariz Med; 1968 Nov; 25(11):974-9. PubMed ID: 5723900
    [No Abstract]   [Full Text] [Related]  

  • 15. Pargyline hydrochloride, methyclothiazide, and deserpidine in therapy of hypertension and prevention of "cheese reaction".
    Hutchison JC
    Curr Ther Res Clin Exp; 1968 Mar; 10(3):128-35. PubMed ID: 4967000
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of essential arterial hypertension by the methyclothiazide-deserpidine].
    de Faria CV
    Rev Bras Med; 1967 May; 24(5):331-3. PubMed ID: 5603874
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypotensive action of the pargyline-methyclothiazide combination].
    Saldanha RV; Adachi T; Silve PP; Giannini SD; Thome O; Diament J
    Rev Bras Med; 1968 Feb; 25(2):102-7. PubMed ID: 5656163
    [No Abstract]   [Full Text] [Related]  

  • 18. Tolerance and ionic effects in hypertensive patients of prolonged administration of an aldosterone antagonist (amiloride) as compared with a thiazide.
    Demanet JC; Paduart P; Fichefet JP; Delcroix C
    J Clin Pharmacol J New Drugs; 1970; 10(4):269-73. PubMed ID: 5269369
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of uncomplicated arterial hypertension with methyclothiazide].
    Spach MO; Bloch R; Imbs JL; Schwartz J
    Therapie; 1978; 33(3):313-20. PubMed ID: 356338
    [No Abstract]   [Full Text] [Related]  

  • 20. [Methyclothiazide in the therapy of patients with heart insufficiency].
    Flensted-Jensen E
    Ugeskr Laeger; 1968 Feb; 130(7):278-81. PubMed ID: 5676614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.